Eran R. Andrechek

4.6k total citations · 1 hit paper
60 papers, 3.2k citations indexed

About

Eran R. Andrechek is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Eran R. Andrechek has authored 60 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 40 papers in Molecular Biology and 16 papers in Cancer Research. Recurrent topics in Eran R. Andrechek's work include Cancer Cells and Metastasis (19 papers), Cancer-related Molecular Pathways (19 papers) and HER2/EGFR in Cancer Research (14 papers). Eran R. Andrechek is often cited by papers focused on Cancer Cells and Metastasis (19 papers), Cancer-related Molecular Pathways (19 papers) and HER2/EGFR in Cancer Research (14 papers). Eran R. Andrechek collaborates with scholars based in United States, Canada and Singapore. Eran R. Andrechek's co-authors include Daniel P. Hollern, Rachel E. Rempel, William J. Muller, Paloma H. Giangrande, Bruce A. Sullenger, James O McNamara, Kristi D. Viles, Yong Wang, Eli Gilboa and Robert D. Cardiff and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Nature Biotechnology.

In The Last Decade

Eran R. Andrechek

59 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras

2006 812 citations Eran R. Andrechek, Rachel E. Rempel et al. profile →

Peers

Countries citing papers authored by Eran R. Andrechek

Since Specialization

Citations

This map shows the geographic impact of Eran R. Andrechek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eran R. Andrechek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eran R. Andrechek more than expected).

Fields of papers citing papers by Eran R. Andrechek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eran R. Andrechek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eran R. Andrechek. The network helps show where Eran R. Andrechek may publish in the future.

Co-authorship network of co-authors of Eran R. Andrechek

This figure shows the co-authorship network connecting the top 25 collaborators of Eran R. Andrechek. A scholar is included among the top collaborators of Eran R. Andrechek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eran R. Andrechek. Eran R. Andrechek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Molecular Characterization and Landscape of Breast cancer Models from a multi-omics Perspective 2023 ·Journal of Mammary Gland Biology and Neoplasia ·(unknown), Eran R. Andrechek	19
2	Elevated phosphorylation of EGFR in NSCLC due to mutations in PTPRH 2022 ·PLoS Genetics ·(unknown), Jonathan Rennhack, (unknown), Daniel P. Hollern, (unknown), R. Kubiak, (unknown), Sandra O’Reilly, Eran R. Andrechek	6
3	A25 PTPRH Mutations in NSCLC Regulate EGFR Phosphorylation 2020 ·Journal of Thoracic Oncology ·(unknown), Jonathan Rennhack, Eran R. Andrechek	1
4	Evaluating cell lines as models for metastatic breast cancer through integrative analysis of genomic data 2019 ·Nature Communications ·(unknown), (unknown), Benjamin S. Glicksberg, Billy Zeng, (unknown), Eran R. Andrechek, Bin Chen	77
5	Identification of an Unfavorable Immune Signature in Advanced Lung Tumors from Nrf2-Deficient Mice 2018 ·Antioxidants and Redox Signaling ·Di Zhang, Jonathan Rennhack, Eran R. Andrechek, Cheryl E. Rockwell, Karen T. Liby	31
6	Transcription factor compensation during mammary gland development in E2F knockout mice 2018 ·PLoS ONE ·(unknown), Eran R. Andrechek	14
7	Mouse Models of Breast Cancer Share Amplification and Deletion Events with Human Breast Cancer 2017 ·Journal of Mammary Gland Biology and Neoplasia ·Jonathan Rennhack, (unknown), (unknown), Eran R. Andrechek	16
8	Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness 2016 ·Cancer Immunology Research ·Lance D. Miller, (unknown), Michael A. Black, Cristin G. Print, Julia Chifman, Angela Alistar, Thomas Choudary Putti, Xiaobo Zhou, Davide Bedognetti, Wouter Hendrickx, Ashok Pullikuth, Jonathan Rennhack, Eran R. Andrechek, Sandra Demaria, Ena Wang, Francesco M. Marincola	76
9	LPA receptor activity is basal specific and coincident with early pregnancy and involution during mammary gland postnatal development 2016 ·Scientific Reports ·(unknown), (unknown), Pilib Ó Broin, Daniel P. Hollern, Silvia E. Racedo, Bernice E. Morrow, Rani S. Sellers, John M. Greally, Aaron Golden, Eran R. Andrechek, Teresa L. Wood, Cristina Montagna	8
10	The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment 2016 ·Oncogene ·(unknown), Ling Chen, Erika J. Crosby, Zachary C. Hartman, (unknown), Lewis A. Chodosh, Jonathan Rennhack, Eran R. Andrechek, (unknown), Michael Hallett, Gordon B. Mills, Robert D. Cardiff, Joe W. Gray, Obi L. Griffith, William J. Muller	52
11	HER2/Neu tumorigenesis and metastasis is regulated by E2F activator transcription factors 2013 ·Oncogene ·Eran R. Andrechek	53
12	NMDA receptor-mediated excitotoxicity depends on the coactivation of synaptic and extrasynaptic receptors 2013 ·Cell Death and Disease ·Xianju Zhou, Daniel P. Hollern, Jiayu Liao, Eran R. Andrechek, (unknown)	158
13	Prediction and Genetic Demonstration of a Role for Activator E2Fs in Myc-Induced Tumors 2011 ·Cancer Research ·Kenichiro Fujiwara, (unknown), Daniel P. Hollern, Eran R. Andrechek	46
14	Heterogeneity in MYC-induced mammary tumors contributes to escape from oncogene dependence 2011 ·Oncogene ·(unknown), Eran R. Andrechek, Robert D. Cardiff, Joseph R. Nevins	12
15	Mouse models of cancers: opportunities to address heterogeneity of human cancer and evaluate therapeutic strategies 2010 ·Journal of Molecular Medicine ·Eran R. Andrechek, Joseph R. Nevins	20
16	A Role for E2F Activities in Determining the Fate of Myc-Induced Lymphomagenesis 2009 ·PLoS Genetics ·Rachel E. Rempel, Seiichi Mori, Maura Gasparetto, Michele A. Glozak, Eran R. Andrechek, (unknown), (unknown), Anand S. Lagoo, Robert W. Storms, (unknown), Joseph R. Nevins	19
17	Expression, location, and interactions of ErbB2 and its intramembrane ligand Muc4 (sialomucin complex) in rat mammary gland during pregnancy 2004 ·Journal of Cellular Physiology ·Shari A. Price‐Schiavi, Eran R. Andrechek, (unknown), Peter Li, Min Rong, Jin Zhang, Coralie A. Carothers Carraway, William J. Muller, Kermit L. Carraway	23
18	Targeted disruption of ErbB2/Neu in the mammary epithelium results in impaired ductal outgrowth 2004 ·Oncogene ·Eran R. Andrechek, Donald White, William J. Muller	56
19	Centrosome abnormalities, recurring deletions of chromosome 4, and genomic amplification of HER2/neu define mouse mammary gland adenocarcinomas induced by mutant HER2/neu 2002 ·Oncogene ·Cristina Montagna, Eran R. Andrechek, Hesed Padilla‐Nash, William J. Muller, Thomas Ried	78
20	Accelerated Mammary Tumor Development in Mutant Polyomavirus Middle T Transgenic Mice Expressing Elevated Levels of Either the Shc or Grb2 Adapter Protein 1999 ·Molecular and Cellular Biology ·Michael J. Rauh, (unknown), Eran R. Andrechek, (unknown), Roger J. Daly, Venus Lai, Tony Pawson, Robert D. Cardiff, Peter M. Siegel, William J. Muller	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact